Correlation Engine 2.0
Clear Search sequence regions


Molecular glues are an intriguing therapeutic modality that harness small molecules to induce interactions between proteins that typically do not interact. However, such molecules are rare and have been discovered fortuitously, thus limiting their potential as a general strategy for therapeutic intervention. We postulated that natural products bearing one or more electrophilic sites may be an unexplored source of new molecular glues, potentially acting through multicovalent attachment. Using chemoproteomic platforms, we show that members of the manumycin family of polyketides, which bear multiple potentially reactive sites, target C374 of the putative E3 ligase UBR7 in breast cancer cells, and engage in molecular glue interactions with the neosubstrate tumor-suppressor TP53, leading to p53 transcriptional activation and cell death. Our results reveal an anticancer mechanism of this natural product family, and highlight the potential for combining chemoproteomics and multicovalent natural products for the discovery of new molecular glues.

Citation

Yosuke Isobe, Mikiko Okumura, Lynn M McGregor, Scott M Brittain, Michael D Jones, Xiaoyou Liang, Ross White, William Forrester, Jeffrey M McKenna, John A Tallarico, Markus Schirle, Thomas J Maimone, Daniel K Nomura. Manumycin polyketides act as molecular glues between UBR7 and P53. Nature chemical biology. 2020 Nov;16(11):1189-1198

Expand section icon Mesh Tags

Expand section icon Substances


PMID: 32572277

View Full Text